| Name | Title | Contact Details |
|---|---|---|
Jean-Claude Saghbini |
Chief Technology Officer | Profile |
DIGITAL HEALTH. UNLOCKED. Join the journey to transform the worlds health. Healthcare is in the middle of a digital revolution, yet the digital health market is unregulated. As the global leader in providing access to trusted digital health technologi...
Network Foundations is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CancerLinQ, a subsidiary of ASCO, is a mission-driven, non-profit health technology company focused on improving quality of care, advancing biomedical research, and improving health outcomes for all patients with cancer. Backed by ASCO, CancerLinQ`s products and services reflect a deep understanding of the needs of oncologists, cancer centers, and researchers. We are bilingual by design: fluent in both the language of oncology and technology. As a trusted partner to over 100 cancer centers and community oncology practices, CancerLinQ is uniquely positioned to advance cancer care and research.
The Public Health Foundation of Columbia County is a Saint Helens, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).